ABOUT CENCORA PHARMALEX
Beginning in January 2024, companies in the PharmaLex family started a journey of rebranding aligned with Cencora, our parent company and a leading global pharmaceutical solutions organization centered on improving lives around the world.
PharmaLex adds to Cencora’s expanding suite of pharma solutions and serves the pharma, biotech, and medtech industries. We guide clients from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-elevated solutions to support clients through the entire product lifecycle.
View our content to discover how our expanded capabilities can help you – or contact a Cencora PharmaLex expert today with any questions.
CONTACT INFORMATION
Cencora PharmaLex
1 W 1st Ave.
Conshohocken, PA 19428
UNITED STATES
EXPLORE OUR THOUGHT LEADERSHIP
Explore the latest insights from the Cencora team.
ARTICLES
-
![GettyImages-942955086 lab]( "Sterility Assurance With Louise Ui Fhatharta")
This discussion explores critical aspects of maintaining sterility in pharmaceutical manufacturing, from facility design and environmental monitoring to regulatory compliance and common misconceptions.
-
![GettyImages-1495954660 plan, maze, strategy, success]( "Pre-Launch Checklist - A Roadmap To Success")
The path from groundbreaking therapy to readily available treatment requires a strategic approach. Delve into ten critical questions that can help you chart a successful course for your CGT therapy.
-
![GettyImages-1181392775 lab, research]( "Navigating The Cell And Gene Regulatory Landscape")
Navigating the complex regulatory landscape is essential for cell and gene therapy success. Explore key considerations, challenges, and best practices for companies operating in this space.
-
![GettyImages-547131922 research, regulatory, lab]( "Navigating The CGT Landscape: Key Takeaways From The FDA's New FAQ")
The FDA's new FAQ on cell and gene therapy offers a roadmap for developers. Review key insights from the document, including the importance of early engagement with the FDA, CMC considerations, and more.
-
![GettyImages-1310986619 patient]( "A Thoughtful Copay Program Design That Increased Patient Engagement")
Learn how a partnership with a pharmaceutical company to redesign patient support materials resulted in increased patient engagement and copay program utilization.
WHITE PAPERS
-
![GettyImages-1026593952 tablet, data]( "Digital Innovation In Pharmacovigilance")
Digital Innovation In PharmacovigilanceExplore how AI can transform your pharmacovigilance efforts and enhance patient safety by leveraging the insights and decision framework outlined here.
-
![Medicine-pills-GettyImages-463594335]( "Mastering The Complexities Of Targeted Medicines")
Mastering The Complexities Of Targeted MedicinesExplore the challenges and strategies involved in developing targeted medicines, with insights into the complexities, collaborations, and considerations necessary for success.
-
![GettyImages-1016958284 biosimilar lab]( "20 Years Of Biosimilars: Are We On The Right Track?")
20 Years Of Biosimilars: Are We On The Right Track?Explore the transformative journey of biosimilars, 20 years in. Through industry expert insights collected from a recent panel discussion, explore regulatory hurdles, market shifts, and the path ahead.
WEBINARS
-
![Driving Product Launch Success In Europe]( "Driving Product Launch Success In Europe")
Driving Product Launch Success In EuropeExplore key steps for preparing your medicinal product for the European market, including insights on challenges, timelines, and a success story.
-
![TMF Excellence]( "TMF SUMMER SHORTS: House Of The Inspector")
TMF SUMMER SHORTS: House Of The InspectorDiscover key steps you can take to not just survive an inspection, but take the TMF Throne.
-
![Ask The Experts]( "Unlock The Secrets Of Managing CTR In A Complex Development Landscape")
Unlock The Secrets Of Managing CTR In A Complex Development LandscapeLost in the CTR maze? Watch this webinar to get your burning questions answered by industry experts. Ask about vendor coordination, CTIS integration, and EU strategies.
PODCASTS
-
![Cencora PharmaLex - PlX talks 30]( "An Overview Of Contamination Control Strategy (CCS)")
An Overview Of Contamination Control Strategy (CCS)Join experts Londa Ritchey and Patrick Nieuwenhuizen as they explore the key role of a contamination control strategy in Annex 1 for ensuring patient safety and continuous manufacturing improvement.
-
![Cencora - PharmaLex Talks 28]( "Early Access Programs: What They Are And How To Plan For Them")
Early Access Programs: What They Are And How To Plan For ThemExplore how early access programs are tailored to individual sufferers of rare, ultra-rare, or life-threatening conditions, as well as cohort programs, which target groups of patients afflicted with the same disease.
-
![Cencora - PharmaLex Talks 27]( "Assessing Gaps And Achieving Compliance With Annex 1")
Assessing Gaps And Achieving Compliance With Annex 1In this podcast episode on Annex 1 compliance and gap assessment, Patrick Nieuwenhuizen shares his insights and expertise gleaned from extensive experience in pharmaceutical regulation and compliance.
E-BOOKS AND OTHER INSIGHTS
-
![GettyImages-547131922 research, regulatory, lab]( "Navigating The CGT Landscape: Key Takeaways From The FDA's New FAQ")
Navigating The CGT Landscape: Key Takeaways From The FDA's New FAQThe FDA's new FAQ on cell and gene therapy offers a roadmap for developers. Review key insights from the document, including the importance of early engagement with the FDA, CMC considerations, and more.
-
![iStock-1287080337-lab-microscope-scientist-research.jpg]( "Unraveling The Complexity Of Cell Therapy: Advancements And Challenges")
Unraveling The Complexity Of Cell Therapy: Advancements And ChallengesCell therapy has emerged as a powerful tool for addressing critical medical challenges, but its rapid evolution necessitates a clear regulatory framework and consistent terminology.
-
![GettyImages-1181392775 lab, research]( "Navigating The Cell And Gene Regulatory Landscape")
Navigating The Cell And Gene Regulatory LandscapeNavigating the complex regulatory landscape is essential for cell and gene therapy success. Explore key considerations, challenges, and best practices for companies operating in this space.
